Teal Health Raises $22M Series A

Teal Health, based in San Francisco, California, is a women's health company that provides an end-to-end at-home HPV cervical cancer screening platform. The company recently announced $22 million in Series A funding, bringing its total funding to $45 million.

Investors

The round was led by .406 Ventures, an early-stage venture capital firm. Additional participating investors include Emerson Collective (managed by Yosemite), Forerunner, Serena Ventures, and MPower Partners.

Teal Health Use of Funds

The new capital will support the expansion of Teal Health's network of payor, health system, employer, and provider partnerships. The funding will also support continued hiring across clinical, commercial, technology, and operational functions to scale the platform ahead of broad insurance coverage beginning in 2027.

About Teal Health

Founded to eliminate cervical cancer, Teal Health offers the Teal Wand, the first FDA-authorized at-home HPV self-collection device for cervical cancer screening. The company provides a telehealth-enabled experience that includes at-home sample collection, secure results delivery, and clinical support for follow-up care.

Funding Details

Company Website: https://getteal.com

Company: Teal Health
Raised: $22M
Round: Series A
Funding Date: September 2026
Lead Investor: .406 Ventures
Additional Investors: Emerson Collective, Forerunner, Serena Ventures, MPower Partners
Company Website: https://www.getteal.com
Software Category: Digital Health
Source: https://www.biospace.com/press-releases/teal-health-raises-22-million-series-a-to-expand-access-to-the-most-accurate-fda-authorized-at-home-hpv-cervical-cancer-screening